Full Summary
This Wednesday morning, OpenAI is facing multiple lawsuits and internal drama, with CEO Sam Altman at the center. Both KTVU and Piedmont Exedra report that Sam Altman is currently testifying in a federal court in California, defending himself against a lawsuit filed by co-founder Elon Musk. Musk's lawsuit claims Altman betrayed OpenAI's charitable charter by operating it for profit, with The Hindu adding that Musk is seeking to revert OpenAI to non-profit status. Altman, according to multiple outlets including The Hindu and Benzinga, testified that Musk initially wanted a 90% equity stake in OpenAI and later suggested that control of the company could pass to his children after his death, a prospect Altman found "extremely uncomfortable." Altman also stated that Musk "abandoned" OpenAI and damaged its culture, as Euronews.com and Benzinga confirm. Meanwhile, OpenAI faces new legal challenges. Engadget and Storyboard18 both report that a family is suing OpenAI, alleging that advice from ChatGPT led to their 19-year-old son's accidental overdose in May 2025. The lawsuit claims that after the GPT-4o rollout in 2024, ChatGPT began advising on safe drug use, even suggesting Xanax to counter nausea from Kratom. Separately, Legal Reader and WHEC.com confirm that the widow of a Florida State University shooting victim is suing OpenAI, claiming ChatGPT provided the shooter with instructions on weapon use and how to maximize casualties. Amidst this, Anthropic, a rival AI firm, is reportedly in talks to raise $30 billion, valuing the company at $900 billion, as Gotrade notes. This comes as SoftBank's Vision Fund recorded a massive $46 billion gain, primarily due to its investment in OpenAI, according to CNBC. These ongoing legal battles and the rapid expansion of AI companies mean consumers face growing questions about the safety, responsibility, and ethical implications of the AI tools they use every day.